Current and prospective treatments for multidrug-resistant gram-positive infections

Author： Rybak Jeffrey M Barber Katie E Rybak Michael J

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.14, 2013-10, pp. : 1919-1932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Daptomycin - a new option for resistant Gram-positive infections

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Novel agents for the treatment of resistant Gram-positive infections

By Woodford Neil

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 117-137

Informa Healthcare

Access to resources Recommend Favorite

Multidrug-Resistant Gram-Negative Bacterial Infections: Are you Ready for the Challenge?

Current Clinical Pharmacology, Vol. 9, Iss. 1, 2014-02 ,pp. : 27-38

Bentham Science Publishers

Access to resources Recommend Favorite

Daptomycin - a novel antibacterial in the fight against resistant Gram-positive infections

Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

Tigecycline for the treatment of infections due to resistant Gram-positive organisms

By Squires Ronald A Postier Russell G

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 155-162

Informa Healthcare

Access to resources Recommend Favorite